Krushna Chandra Hembram

Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages

Rajalaxmi Pradhan, Subhajit Chatterjee, Krushna Chandra Hembram et al. · The Journal of Nutritional Biochemistry · 2021 · 79 citations

Nanomedicine, Inflammatory Cytokines, Oncology +11

PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)

Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla et al. · Cellular Signalling · 2020 · 48 citations

Oncology, Parp Inhibitor Veliparib, Nitric Oxide +11

PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade

Sefinew Molla, Krushna Chandra Hembram, Subhajit Chatterjee et al. · Pathology & Oncology Research · 2019 · 28 citations

Ber Cascade, Parp Inhibitor Olaparib, Oncology +10

Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer

Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy et al. · Molecular Pharmaceutics · 2019 · 24 citations

Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells

Krushna Chandra Hembram, Somya Ranjan Dash, Biswajit Das et al. · Molecular Pharmaceutics · 2020 · 20 citations